IBB Holdings Information

IBB is an equity ETF with a total of 260 individual holdings. The top holdings are Gilead Sciences stock at 9.61%, Vertex Pharmaceuticals at 8.95%, Amgen at 8.93%, Regeneron Pharmaceuticals at 6.78%, and Alnylam Pharmaceuticals at 3.61%.

Total Holdings

260

Top 10 Percentage

49.83%

Asset Class

Equity

ETF Category

Health

Assets

8.78B

PE Ratio

22.86

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	9.61%	5,472,252
2	VRTX	Vertex Pharmaceuticals Incorporated	8.95%	1,588,124
3	AMGN	Amgen Inc.	8.93%	1,993,356
4	REGN	Regeneron Pharmaceuticals, Inc.	6.78%	744,274
5	ALNY	Alnylam Pharmaceuticals, Inc.	3.61%	954,436
6	INSM	Insmed Incorporated	2.70%	1,546,876
7	ARGX	argenx SE	2.65%	297,696
8	NTRA	Natera, Inc.	2.38%	966,035
9	BIIB	Biogen Inc.	2.35%	1,077,186
10	ONC	BeOne Medicines AG	1.88%	531,831
11	UTHR	United Therapeutics Corporation	1.81%	305,506
12	ILMN	Illumina, Inc.	1.68%	1,092,368
13	INCY	Incyte Corporation	1.66%	1,428,323
14	MRNA	Moderna, Inc.	1.51%	2,549,284
15	RVMD	Revolution Medicines, Inc.	1.45%	1,215,858
16	GMAB	Genmab A/S	1.19%	3,616,587
17	NBIX	Neurocrine Biosciences, Inc.	1.11%	714,034
18	IONS	Ionis Pharmaceuticals, Inc.	1.09%	1,168,374
19	ROIV	Roivant Sciences Ltd.	1.05%	3,182,833
20	ASND	Ascendis Pharma A/S	0.97%	340,741
21	BMRN	BioMarin Pharmaceutical Inc.	0.97%	1,392,360
22	BBIO	BridgeBio Pharma, Inc.	0.93%	1,210,248
23	EXEL	Exelixis, Inc.	0.92%	1,909,867
24	MEDP	Medpace Holdings, Inc.	0.92%	166,204
25	USD	USD CASH	0.91%	76,895,683

Showing 25 of 260 holdings

Subscribe to see the full list

Activate Now

As of Mar 3, 2026